The U.S. Food and Drug Administration has granted orphan drug designation status to a novel, humanized monoclonal antibody APX005M (Apexigen) for the treatment of esophageal and gastroesophageal junction cancer and for the treatment of pancreatic cancer.

“These orphan drug designations are important regulatory milestones for Apexigen in its mission to treat cancer patients and for APX005M, which has the potential to…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Jul 26, 2020

Pooled data shows tazemetostat safe, effective in patients with epithelioid sarcoma

Tazemetostat provides clinically meaningful, durable, single agent activity in patients with epithelioid sarcoma, according to data presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program…

Journal Scan

  1. Oct 13, 2020

Case Report: Sarcoma with metastatic pulmonary dissemination mimics COVID-19 clinical features

In this case report, a 13-year-old boy with fever, dry cough, persistent asthenia and impaired general condition of 2 weeks' duration, presented to the hospital. Bloodwork showed a severe inflammatory status and X-rays were consistent with bilateral COVID-19…